Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 30;6(5):502-6.
doi: 10.1021/ml5004298. eCollection 2015 May 14.

Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors

Affiliations

Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors

Wei Zhang et al. ACS Med Chem Lett. .

Abstract

α1-Adrenergic receptors (α1-ARs), as the essential members of G protein-coupled receptors (GPCRs), can mediate numerous physiological responses in the sympathetic nervous system. In the current research, a series of quinazoline-based small-molecule fluorescent probes to α1-ARs (1a-1e), including two parts, a pharmacophore for α1-AR recognition and a fluorophore for visualization, were well designed and synthesized. The biological evaluation results displayed that these probes held reasonable fluorescent properties, high affinity, accepted cell toxicity, and excellent subcellular localization imaging potential for α1-ARs.

Keywords: cell imaging; fluorescent probes; quinazoline; subcellular localization; α1-Adrenergic receptors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Scheme 1
Scheme 1. Structures of Quinazoline Derivatives as α1-AR Antagonists
Scheme 2
Scheme 2. Designed Quinazoline-Based Fluorescent Probes for α1-ARs
Figure 1
Figure 1
Proposed docking conformation of prazosin (red sticks) and 1a (white sticks) in the human α1A-AR binding site.
Scheme 3
Scheme 3. Synthetic Routes of Designed Fluorescent Probes
Figure 2
Figure 2
Confocal fluorescence image of HEK293 cell using compound 1a. All cells are incubated with 1a at 37 °C for 5 min and washed immediately, and the exposure time is the same. The background was adjusted by ImageJ software. (A) Image of HEK293A-α1A-AR cells incubated with 1a (15 nM) and DiD; (B) image of HEK293A-α1D-AR cells incubated with 1a (15 nM) and DiD; (C) image of HEK293A cells incubated with 1a (15 nM) and DID; (D) image of HEK293A-α1A-AR cells incubated with 1a (15 nM), DID, and tamsulosin (300 nM); (E) image of HEK293A-α1D-AR cells incubated with 1a (15 nM), DID, and tamsulosin (300 nM). Scale bar (yellow) = 20 μm.
Figure 3
Figure 3
Fluorescence image of cancer cells using compound 1d. The background was adjusted by ImageJ software. (A) PC-3 cells were with incubated with 1d (1 μM) at 37 °C for 30 min, then washed immediately; (B) PC-3 cells were with incubated with 1d (1 μM) and doxazosin (10 μM) at 37 °C for 30 min, then washed immediately; (C) HepG2 cells were incubated with 1d (1 μM) at 37 °C for 30 min, then washed immediately. Scale bar (yellow) = 20 μm.

Similar articles

Cited by

References

    1. Li W.; Du L.; Li M. Alkaloids and flavonoids as α1-adrenergic receptor antagonists. Curr. Med. Chem. 2011, 18, 4923–4932. - PubMed
    1. Ruffolo R. R. Jr; Hieble J. P. Adrenoceptor pharmacology: urogenital applications. Eur. Urol. 1999, 36, 17–22. - PubMed
    1. Forray C.; Noble S. A. Subtype selective α1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia. Expert Opin. Invest. Drug. 1999, 8, 2073–2094. - PubMed
    1. Nagarathnam D.; Wetzel J.; Miao S.; Marzabadi M.; Chiu G.; Wong W.; Hong X.; Fang J.; Forray C.; Branchek T. Design and synthesis of novel α1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia. J. Med. Chem. 1998, 41, 5320–5333. - PubMed
    1. Jarajapu Y. P. R.; Coats P.; McGrath J. C.; Hillier C.; MacDonald A. Functional characterization of α1-adrenoceptor subtypes in human skeletal muscle resistance arteries. Br. J. Pharmacol. 2001, 133, 679–686. - PMC - PubMed

LinkOut - more resources